{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:44Z","timestamp":1792088204987,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"vor","delay-in-days":531,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Canadian Cancer Society","award":["P#20001191"],"award-info":[{"award-number":["P#20001191"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.molmet.2016.08.014","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T07:16:08Z","timestamp":1472800568000},"page":"1048-1056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":230,"title":["The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration"],"prefix":"10.1016","volume":"5","author":[{"given":"Linda A.","family":"Villani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Marcinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Broadfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex E.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa P.","family":"Houde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Muti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Tsakiridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2016.08.014_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diaclin.28.1.5","article-title":"Apple trees to sodium-glucose co-transporter inhibitors: a review of SGLT2 inhibition","volume":"28","author":"White","year":"2010","journal-title":"Clinical Diabetes"},{"key":"10.1016\/j.molmet.2016.08.014_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40265-014-0337-y","article-title":"Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus","volume":"75","author":"Scheen","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.molmet.2016.08.014_bib3","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1172\/JCI67232","article-title":"Potential applications for biguanides in oncology","volume":"123","author":"Pollak","year":"2013","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2016.08.014_bib4","author":"ClinicalTrials.gov. Bethesda"},{"key":"10.1016\/j.molmet.2016.08.014_bib5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2016.08.014_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.molmet.2016.08.014_bib7","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.53.4.1052","article-title":"Thiazolidinediones, like metformin, inhibit respiratory complex I.","volume":"53","author":"Brunmair","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2016.08.014_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"Journal of Clinical Investestigation"},{"key":"10.1016\/j.molmet.2016.08.014_bib9","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/j.molmet.2016.08.014_bib10","doi-asserted-by":"crossref","first-page":"25226","DOI":"10.1074\/jbc.M202489200","article-title":"The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways","volume":"28","author":"Fryer","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2016.08.014_bib11","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","article-title":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism","volume":"8","author":"Hawley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2016.08.014_bib12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in health and disease","volume":"89","author":"Steinberg","year":"2009","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.molmet.2016.08.014_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1\u2013AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.molmet.2016.08.014_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1748-1716.2009.01972.x","article-title":"LKB1 and AMP-activated protein kinase control of mTOR signalling and growth","volume":"196","author":"Shaw","year":"2009","journal-title":"Acta Physiologica (Oxford, England)"},{"key":"10.1016\/j.molmet.2016.08.014_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20150122","article-title":"Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex\u00a0vivo through inhibition of de novo lipogenesis","volume":"469","author":"O'Brien","year":"2015","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.molmet.2016.08.014_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the warburg effect and suppresses tumor growth in\u00a0vivo","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell Metabolism"},{"issue":"Suppl.","key":"10.1016\/j.molmet.2016.08.014_bib17","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.semcancer.2015.10.002","article-title":"Dysregulated metabolism contributes to oncogenesis","volume":"35","author":"Hirschey","year":"2015","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.molmet.2016.08.014_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2014.01.018","article-title":"The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator","volume":"356","author":"Faubert","year":"2015","journal-title":"Cancer Letters"},{"key":"10.1016\/j.molmet.2016.08.014_bib19","doi-asserted-by":"crossref","first-page":"e02242","DOI":"10.7554\/eLife.02242","article-title":"Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis","volume":"3","author":"Wheaton","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.molmet.2016.08.014_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13110","article-title":"Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides","volume":"508","author":"Birsoy","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2016.08.014_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1002309","article-title":"Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis","volume":"13","author":"Griss","year":"2015","journal-title":"PLoS Biology"},{"key":"10.1016\/j.molmet.2016.08.014_bib22","doi-asserted-by":"crossref","first-page":"E4111","DOI":"10.1073\/pnas.1511698112","article-title":"Functional expression of sodium-glucose transporters in cancer","volume":"112","author":"Scafoglio","year":"2015","journal-title":"PNAS USA"},{"key":"10.1016\/j.molmet.2016.08.014_bib23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1507\/endocrj.EJ15-0396","article-title":"Effect of dapagliflozin on colon cancer cell","volume":"62","author":"Saito","year":"2015","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.molmet.2016.08.014_bib24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/pros.20617","article-title":"Effect of metabolic inhibitors on ATP and citrate concent in PC3 prostate cancer cells","volume":"67","author":"Matheson","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.molmet.2016.08.014_bib25","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","article-title":"Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells","volume":"70","author":"Ben Sahra","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.molmet.2016.08.014_bib26","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/glucose co-transporter inhibitor canagliflozin activates AMP-activated protein kinase by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2016.08.014_bib27","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1128\/MCB.20.18.6704-6711.2000","article-title":"Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase","volume":"20","author":"Woods","year":"2000","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.molmet.2016.08.014_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nm1383","article-title":"CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK","volume":"12","author":"Watt","year":"2006","journal-title":"Nature Medicine"},{"key":"10.1016\/j.molmet.2016.08.014_bib29","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/nm.3372","article-title":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin","volume":"19","author":"Fullerton","year":"2013","journal-title":"Nature Medicine"},{"key":"10.1016\/j.molmet.2016.08.014_bib30","author":"The Human Protein Atlas. Stockholm"},{"key":"10.1016\/j.molmet.2016.08.014_bib31","doi-asserted-by":"crossref","first-page":"e28536","DOI":"10.1371\/journal.pone.0028536","article-title":"Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells","volume":"6","author":"Aguer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2016.08.014_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","article-title":"Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation","volume":"11","author":"Hawley","year":"2010","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2016.08.014_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1074\/jbc.M109.056762","article-title":"AMPK beta-1 deletion reduces appetite, preventing obesity and hepatic insulin resistance","volume":"285","author":"Dzamko","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2016.08.014_bib34","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1073\/pnas.95.16.9167","article-title":"Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells","volume":"95","author":"Seo","year":"1998","journal-title":"PNAS USA"},{"key":"10.1016\/j.molmet.2016.08.014_bib35","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1021\/jm100332n","article-title":"Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus","volume":"53","author":"Nomura","year":"2010","journal-title":"Journal of Medical Chemistry"},{"key":"10.1016\/j.molmet.2016.08.014_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4172\/1948-5956.1000159","article-title":"Sodium\/glucose co-transporter 1 expression increases in human diseased prostate","volume":"4","author":"Blessing","year":"2012","journal-title":"Journal of Cancer Science and Therapy"},{"key":"10.1016\/j.molmet.2016.08.014_bib37","first-page":"3057","article-title":"Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma","volume":"5A","author":"Effert","year":"2004","journal-title":"Anticancer Research"},{"key":"10.1016\/j.molmet.2016.08.014_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.molmet.2016.08.014_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0021-9258(19)77256-1","article-title":"Cofactor requirements for lipogenesis","volume":"205","author":"Van Baalen","year":"1953","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2016.08.014_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-015-0138-0","article-title":"Targeting mitochondrial complex I using BAY 87-2242 reduces melanoma tumor growth","volume":"3","author":"Schockel","year":"2015","journal-title":"Cancer and Metabolism"},{"key":"10.1016\/j.molmet.2016.08.014_bib41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3596","article-title":"Overcoming Drug development bottlenecks with repurposing: repurposing biguanides to target energy metabolism for cancer treatment","volume":"5","author":"Pollak","year":"2014","journal-title":"Nature Medicine"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877816301314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877816301314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T15:43:18Z","timestamp":1657208598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877816301314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2212877816301314"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2016.08.014","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2016.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Author(s). Published by Elsevier GmbH","name":"copyright","label":"Copyright"}]}}